Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus.

Authors:
Kim JH; Yoon YC; Kim YH; Park JI; Choi KU and 5 more

Journal:
Clin Cardiol

Publication Year: 2024

DOI:
10.1002/clc.24248

PMCID:
PMC10910463

PMID:
38436204

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Clin Cardiol

Detailed journal information not available.

Publication Details

Subject Category: Cardiac & Cardiovascular Systems

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT Dr. J‐I Park received funding from the 2023 Yeungnam University Research Grant. The other authors declare no conflicts of interest."

Funding Disclosure

Evidence found in paper:

"The authors thank the Medical R&D Service Design Center of Yeungnam University College of Medicine for all artistic support related to this work. Dr. J‐I Park received funding from the 2023 Yeungnam University Research Grant. The other authors declare no conflicts of interest."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025